San Francisco startup Framework Therapeutics can also be engaged on an oral, as soon as-every day GLP-1 drug called GSBR-1290—the drug surpassed Wall Avenue’s anticipations in June when a mid-phase review showed typical weight loss of about six% and it options to get started on An additional mid-phase trial towards the tip of the year—that fo